Business
Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results
Q4 Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023 FY 2024 Net Revenue of $273.9 million, 27.5% Comparable Net Revenue Growth and $40.3 million of Adjusted EBITDA Obagi Medical is the fastest growing professional skincare brand1 in the US in 2024 Milk Makeup expands its distribution to Ulta Beauty Waldencast secures a new $205 million credit facility, replacing the current one, enhancing flexibility and extending debt
About this update from Waldencast Plc
[{"type":"image","alt":"Waldencast plc.","displaySize":"","headline":null,"caption":"Waldencast plc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/5e6e09136f63d32ac7a9583d415634e6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1j8EsuxHarwHbD29Bm8Ldg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/5e6e09136f63d32ac7a9583d415634e6","width":300,"height":36}},"lazy":false},{"type":"text","content":"Q4 Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023","length":128,"tagName":"p"},{"type":"text","content":"FY 2024 Net Revenue of $273.9 million, 27.5% Comparable Net Revenue Growth and $40.3 million of Adjusted EBITDA","length":111,"tagName":"p"},{"type":"text","content":"Obagi Medical is the fastest growing professional skincare brand1 in the US in 2024","length":83,"tagName":"p"},{"type":"text","content":"Milk Makeup expands its distribution to Ulta Beauty","length":51,"tagName":"p"},{"type":"text","content":"Waldencast secures a new $205 million credit facility, replacing the current one, enhancing flexibility and extending debt maturity","length":131,"tagName":"p"},{"type":"text","content":"LONDON, March 18, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended December 31, 2024 (“Q4 2024”) and the year ended December 31, 2024 (the “Year Ended 2024”) on Form 6-K to the U.S. Securities and Exchange Commission (the “SEC”), which are also available on our investor relations site at http://ir.waldencast.com/.","length":465,"tagName":"p"},{"type":"text","content":"Michel Brousset, Waldencast Founder and CEO, said: “We closed a transformative year for the Group, achieving outstanding growth, expanding our brands' communities, and making significant progress on our strategic priorities. Our business model is driven by a powerful flywheel effect of growth and profitability. This begins with the unique strength of our brands, which is amplified by our ability to enhance operational efficiency. As a result, we can effectively increase investments in sales and marketing to drive profitable growth. In 20...